Regulus Therapeutics (NASDAQ:RGLS) Earns “Hold” Rating from Jones Trading
Jones Trading reissued their hold rating on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research note released on Wednesday, MarketBeat reports. They currently have a $7.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $8.00. Other equities research analysts have also issued research reports about the […]
Jones Trading reissued their hold rating on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a research note released on Wednesday, MarketBeat reports. They currently have a $7.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $8.00. Other equities research analysts have also issued research reports about the […]
